2 recruiting, 1 not yet recruiting. 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
Follow Standard Lipid-Lowering Therapy: new trials by email Literature Review of Standard Lipid-Lowering Therapy trials Research Report on Standard Lipid-Lowering Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Very Early PCSK9 Inhibition for Acute Myocardial Infarction Standard Lipid-Lowering Therapy, Early Intensive Lipid-Lowering Therapy (PCSK9 Inhibitor) - Acute Myocardial Infarction (AMI) | Not applicable | Recruiting | Shanghai Zhongshan Hospital | 1518 | 2026-01-01 | 2026-01-27 |
| CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS Evolocumab, Serial photon-counting coronary computed tomography angiography, Standard Lipid-Lowering Therapy - Coronary, Coronary Artery Disease | Phase 4 | Recruiting | West China Hospital | 232 | 2025-11-19 | 2026-10-07 |
| Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study PCSK9 inhibitor, Standard Lipid-Lowering Therapy - Coronary Artery Disease | Phase 4 | Not yet recruiting | Hanyang University Seoul Hospital | 352 | 2025-07-01 | 2025-07-24 |
Coronary Artery Disease (2) · Acute Coronary Syndrome (1) · Hypercholesterolemia, Autosomal Dominant, 3 (1)
Hanyang University Seoul Hospital (1) · Shanghai Zhongshan Hospital (1) · West China Hospital (1)
China (2)
Yong He (1)